LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
11.59
-0.46 (-3.82%)
At close: Feb 20, 2026, 4:00 PM EST
11.50
-0.09 (-0.78%)
After-hours: Feb 20, 2026, 7:59 PM EST
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $362.65 million as of February 20, 2026. Its market cap has decreased by -50.78% in one year.
Market Cap
362.65M
Enterprise Value
161.43M
1-Year Change
-50.78%
Ranking
Category
Stock Price
$11.59
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $362.65M, a decrease of -12.33%. That is a compound annual growth rate of -6.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 362.65M | -27.56% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 381.81M |
| NovaBridge Biosciences | 379.31M |
| Bicycle Therapeutics | 372.51M |
| Monopar Therapeutics | 370.28M |
| Century Therapeutics | 370.07M |
| Protara Therapeutics | 366.54M |
| Adlai Nortye | 366.05M |
| Benitec Biopharma | 364.47M |